Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

Hair loss treatments work better with lifestyle changes.

Finasteride effectively treats male hair loss, improving growth and density.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Hair loss patients have different microbes in hair follicles, possibly affecting hair loss.

Finasteride has a higher risk of reproductive side effects than minoxidil.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Methyl vanillate spray increases hair count and hair mass in women with hair loss.

Women with PCOS often have more sleep problems than the general population.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Finasteride does not prevent bladder cancer.

Finasteride affects young male rats' brain function and behavior negatively.

Finasteride and analogues separated using LC-MS-MS technique.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Only 22% of teenage girls in the study knew about PCOS, despite many having symptoms.

Rumex japonicus extract may promote hair growth more effectively than Minoxidil.

Current research explores hair growth drugs, while future research aims for personalized treatments.

LLLT is a safe, promising hair loss treatment, but more research needed.